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We have previously reported that the 3C-like proteinase of the coronavirus infectious bronchitis virus (IBV) is responsible
for processing of the 1a and 1a/1b polyproteins to three mature products of 24, 10, and 100 kDa (Liu et al., 1994, 1997; Ng
and Liu, 1998). The C-terminal cleavage site of the 100-kDa protein was defined to be the Q891(1b)-S892(1b) dipeptide bond
encoded by nucleotides 15,129 to 15,134 (Liu and Brown, 1995). In this report, other cleavage sites of the 3C-like proteinase
in the polyprotein encoded by the ORF 1b region were mapped by coexpression, deletion, and site-directed mutagenesis
studies. Using two ORF 1b-specific antisera, V58 and V17, three more Q-S(G) dipeptide bonds, encoded by nucleotides 16,929
to 16,934, 18,492 to 18,497, and 19,506 to 19,511, respectively, were demonstrated to be the cleavage sites of the 3C-like
proteinase. Cleavage at these four positions would result in the release of four mature products with molecular masses of
approximately 68, 58, 39, and 35 kDa. Among them, the 39- and 35-kDa proteins were specifically identified in IBV-infected
cells. Taken together with the 100-kDa protein previously identified, these results suggest that the ORF 1b region of IBV
mRNA1 may be able to encode five mature products. © 1998 Academic Press
INTRODUCTION
Coronavirus gene expression involves the production
of six to seven mRNA species. The prototype species of
the Coronaviridae, avian infectious bronchitis virus (IBV),
encodes six mRNA species in virus-infected cells. These
include the genome-length mRNA (mRNA1) of 27.6 kilo-
bases (kb) and five subgenomic mRNA species (mRNAs
2–6) with sizes ranging from 2 to 7 kb. The available
evidence demonstrates that the four virion structural
proteins, spike (S), membrane (M), nucleocapsid (N), and
small envelope (E), are encoded by subgenomic mRNA
2, mRNA 4, mRNA 6, and the third ORF of mRNA 3,
respectively (Liu and Inglis, 1991; Stern and Sefton, 1984).
Nucleotide sequencing of the genomic RNA of IBV has
shown that the 59-terminal unique region of mRNA 1
contains two large ORFs (1a and 1b), with ORF 1a having
the potential to encode a polyprotein of 441 kDa (1a
polyprotein) and 1b having the potential to encode a
polyprotein of 300 kDa (Boursnell et al., 1987) (Fig. 1). The
downstream ORF 1b is produced as a fusion protein of
741 kDa with 1a (1a/1b polyprotein) by a ribosomal
frameshift (Brierley et al., 1987, 1989). The 1a and 1a/1b
polyproteins are expected to be cleaved by viral or cel-
lular proteinases to produce functional products associ-
ated with viral RNA replication (Fig. 1).
Three proteinase domains have been predicted to be
involved in cleavage of the 1a and 1a/1b polyproteins.
These include two overlapping papain-like proteinase
domains encoded by ORF 1a from nucleotide 4242 to
5553 and one serine proteinase domain of the picorna-
virus 3C proteinase group (3C-like proteinase) encoded
between nucleotides 8937 and 9357 (Gorbalenya et al.,
1989; Lee et al., 1991) (Fig. 1). The first papain-like pro-
teinase domain has been demonstrated to be involved in
processing of the 1a polyprotein to an 87-kDa mature
viral product (Liu et al., 1995; Lim and Liu, 1998). A more
important role in the processing of the 1a and 1a/1b
polyproteins may be played by the 3C-like proteinase
domain, as more than 10 Q-S(G) dipeptide bonds have
been predicted to be the cleavage sites of this protein-
ase (Gorbalenya et al., 1989). Indeed, three mature viral
products of 24, 10, and 100 kDa have been demonstrated
to be released from the 1a and 1a/1b polyproteins by the
3C-like proteinase-mediated proteolysis (Liu et al., 1994,
1997; Liu and Brown, 1995; Ng and Liu, 1998). Charac-
terization of the 3C-like proteinase demonstrates that the
catalytic center of this proteinase is composed of the
predicted nucleophilic cysteine residue (Cys2922) and the
histidine 2820 (His2820) residue (Liu and Brown, 1995).
Meanwhile, in vitro expression data suggest that this
proteinase may be released from the 1a polyprotein as a
35-kDa protein by autoprocessing at two previously pre-
dicted Q-S (Q2779-S2780 and Q3086-S3087) dipeptide bonds
(Tibbles et al., 1996) (see Fig. 1).
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Identification and characterization of cleavage prod-
ucts from the 1a and 1a/1b polyproteins have also
been reported for human coronavirus and mouse hep-
atitis virus. In the case of human coronavirus, four
mature products have been identified. These include a
34-kDa protein representing the 3C-like proteinase, a
105-kDa protein corresponding to the 100-kDa protein
of IBV, a 71-kDa protein with an ATPase activity, and a
41-kDa protein processed from the 1b polyprotein
(Ziebuhr et al., 1995; Grotzinger et al., 1996; Heusipp et
al., 1997a,b). Similarly, three mature products, includ-
ing two N-terminal cleavage products of 28 and 65 kDa
and a 27-kDa protein identified as the 3C-like protein-
ase, have been reported for mouse hepatitis virus
(Denison and Perlman, 1987; Denison et al., 1995; Lu et
al., 1995).
In this communication, we report experiments de-
signed to map the cleavage sites of the 3C-like pro-
teinase in the polyprotein encoded by ORF 1b. Two
ORF 1b-specific antisera, V58 and V17 (Fig. 1), were
used in this study. Cotransfection, deletion, and site-
directed mutagenesis studies demonstrated that three
more Q-S(G) cleavage sites, encoded by nucleotides
16929 to 16934, 18492 to 18497, and 19506 to 19511,
respectively, were recognized and cleaved by the 3C-
like proteinase. Taken together with the two cleavage
sites identified for releasing the 100-kDa protein,
cleavage at these positions would result in the release
of five mature products with molecular masses of
approximately 100, 68, 58, 39, and 35 kDa (Fig. 1).
Among them, the 100-, 39-, and 35-kDa proteins were
specifically identified in IBV-infected cells. Information
gained from this study could be used to guide further
identification and characterization of the ORF 1b-spe-
cific products.
RESULTS
Mutational analysis of the putative Q1491(1b)-G1492(1b)
cleavage site
We have previously reported the identification of a
100-kDa protein encoded by nucleotides 12,313 to 15,131
in IBV-infected Vero cells using an ORF 1b-specific anti-
serum V58 (Liu et al., 1994; Liu and Brown, 1995). Two
Q-S dipeptide bonds (Q3928-S3929 and Q891(1b)-S892(1b))
encoded by nucleotides 12,310 to 12,315 and 15,129 to
15,134, respectively, were determined to be the N- and
C-terminal cleavage sites of the 100-kDa protein. In ad-
dition to the Q891(1b)-S892(1b) dipeptide bond, three more
potential cleavage sites of the 3C-like proteinase have
been predicted to be located in the 1b polyprotein (Fig.
1). The first one is the Q1491(1b)-G1492(1b) dipeptide bond
FIG. 1. Diagram showing the structure of ORF 1a and 1b and proteolytic processing map of the 1a/1b polyprotein. The locations of putative
functional domains are shown. PLP, papain-like proteinase; 3CLP, 3C-like proteinase; CR, cysteine-rich region; RdRP, RNA-dependent RNA
polymerase; MB, metal-binding domain; RH, RNA helicase. Also shown are the regions used to raise antisera V58 and V17 and the positions of 10
identified Q-S(N, G) cleavage sites of the 3C-like proteinase. The precise amino acid positions of the 10 cleavage sites and the nucleotides encoding
these dipeptide bonds (given in parentheses) are as follows: 1, Q2779-S2780 (8863–8868); 2, Q3086-S3087 (9784–9789); 3, Q3462-S3463 (10,912–10,917); 4,
Q3472-N3473 (11,542–11,547); 5, Q3783-S3784 (11,875–11,880); 6, Q3928-S3929 (12,310–12,315); 7, Q891(1b)-S892(1b) (15,129–15,134); 8, Q1491(1b)-S1492(1b) (16,929–
16,934); 9, Q2012(1b)-S2013(1b) (18,492–18,497); 10, Q2350(1b)-S2351(1b) (19,506–19,511). The first amino acid position of polyprotein encoded by ORF 1b was
counted from the methionine residue encoded by nucleotides 12,459 to 12,461.
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encoded by nucleotides 16,929 to 16,934 (Fig. 1). In order
to test if this is a genuine scissile bond of the 3C-like
proteinase, plasmid pIBV14D1Q891(1b)-E (Fig. 2a), which
was constructed for studying the C-terminal cleavage
site of the 100-kDa protein (see Liu and Brown, 1995),
was first expressed in Vero cells. As the Q891(1b)-E mu-
tation introduced in this construct significantly reduced
the cleavage efficiency occurring at the Q891(1b)-S892(1b)
dipeptide bond, it would allow us to use antiserum V58,
which recognizes the 100-kDa protein only, to detect a
fusion product containing the 100-kDa protein and prod-
ucts encoded by the downstream region (see Fig. 2a). As
expected, expression of pIBV14D1Q891(1b)-E led to the
detection of four polypeptides by immunoprecipitation
with antiserum V58 (Fig. 2b, lane 6). In addition to the
100-kDa cleavage product and a 160-kDa protein repre-
senting the full-length product expressed from this con-
struct, a 125-kDa protein and a product migrating slightly
more slowly on SDS–PAGE than the 125-kDa product
were observed (Fig. 2b, lane 6). The estimated molecular
weight of the latter species is approximately 130 kDa
(Fig. 2b, lane 6). The apparent molecular masses of
these two products and their expression patterns sug-
gest that the C-termini of the 125- and 130-kDa proteins
may be derived, respectively, from cleavage occurring at
the Q1491(1b)-G1492(1b) dipeptide bond and from termina-
tion of translation at a UAA termination codon 47 amino
acid residues downstream of the G1492(1b) residue (see
Fig. 2a). It is therefore likely that cleavage may occur at
the Q1491(1b)-G1492(1b) dipeptide bond.
To support this possibility further, plasmid pIBV21 was
constructed and expressed. This plasmid was based on
pIBV14D1Q891(1b)-E, but the Q1491(1b) residue was mu-
tated to an M by PCR (Fig. 2a). Meanwhile, the 39 end of
the IBV sequence present in pIBV14D1Q891(1b)-E was
extended up to nucleotide 17,630 (Fig. 2a). As can be
seen, expression of pIBV21 resulted in the detection of
three products (Fig. 2b, lane 5). In addition to the 100-kDa
protein and the 180-kDa full-length product, a protein
species migrating on SDS–PAGE much more slowly than
the 125-kDa protein was observed (Fig. 2b, lane 5). Its
apparent molecular weight of approximately 155 kDa
suggested that it is a fusion protein comprising the
125-kDa protein and the product encoded by nucleotides
16,932 to 17,630 (Fig. 2a). These results confirm that
mutation of the Q1491(1b) residue to an M completely
blocked cleavage occurring at this position and suggest
that the Q1491(1b)-G1492(1b) dipeptide bond is a cleavage
site of the 3C-like proteinase.
FIG. 2. (a) Diagram showing the IBV sequences present in plasmids pIBV14D1Q891(1b)-E and pIBV21. The IBV sequence used to raise
antiserum V58 and the substitution mutations introduced are indicated. Also shown are the predicted cleavage products that could be detected
by immunoprecipitation with antiserum V58 and a UAA termination codon located 47 amino acid residues downstream of the G1492(1b) residue.
(b) Analysis of transiently expressed products from transfection of plasmids pIBV14D1Q891(1b)-E and pIBV21. Plasmid DNAs were expressed in
Vero cells using the vaccinia virus-T7 expression system (Fuerst et al., 1986). Semiconfluent monolayers of Vero cells were infected with a
recombinant vaccinia virus (vTF7-3) and transfected with plasmid DNA using DOTAP according to the instructions of the manufacturer
(Boehringer Mannheim). Cells were labeled with [35S]methionine, lysates were prepared, and polypeptides were either analyzed directly (lanes
1–3) or immunoprecipitated with antiserum V58 (lanes 4–6). The radiolabeled polypeptides were separated on an SDS–12.5% polyacrylamide
gel and detected by fluorography. Control DNA (lanes 1 and 4)-a plasmid contains the IBV sequence from nucleotides 8693 to 13,896. HMW,
high molecular weight markers (numbers indicate kilodaltons).
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Proteolytic processing of products encoded by the
39-terminal 3.5-kb region of ORF 1b
We next set up to analyze if the two predicted cleavage
sites (Q2012(1b)-S2013(1b) and Q2350(1b)-S2351(1b)) encoded by
nucleotides 18,492 to 18,497 and 19,506 to 19,511, re-
spectively, are cleavage sites of the 3C-like proteinase
(see Fig. 1). For this purpose, plasmid pIBV1b4, which
covers the IBV sequence from nucleotides 16,932 to
20,490 (Fig. 3a) was expressed either on its own or
together with pIBV3C, a plasmid which contains the IBV
sequence coding for the 3C-like proteinase and has
been shown to possess trans-cleavage activity (Liu et al.,
1997). As the results in Fig. 3b show, expression of
pIBV1b4 in Vero cells led to the synthesis of a protein
with an apparent molecular mass of approximately 132
kDa, representing the full-length product encoded by this
construct; this product was immunoprecipitated by anti-
serum V17 (Fig. 3b, lane 1). No processing of the 132-kDa
protein to smaller products was observed (Fig. 3b, lane
1). Cotransfection of pIBV1b4 with pIBV3C, however, re-
sulted in the detection of five protein species (Fig. 3b,
lane 2). In addition to the 132-kDa full-length product, four
other protein species with apparent molecular masses of
approximately 97, 74, 39, and 35 kDa, respectively, were
also detected (Fig. 3b, lane 2). Among them, the 132-, 97-,
74-, and 39-kDa products were immunoprecipitated effi-
ciently by antiserum V17; only trace amount of the 35-kDa
protein, however, was detected from the same cell lysate
(Fig. 3b, lane 2). These results suggest that the four
smaller products may represent mature and intermediate
cleavage products of the 132-kDa polyprotein.
Pulse–chase and time course experiments were then
carried out to define further the processing pattern of the
products expressed from cotransfection of pIBV1b4 and
pIBV3C. For this purpose, Vero cells were cotransfected
with pIBV1b4 and pIBV3C, labeled with [35S]methionine
for 4 h at 13 h posttransfection, and chased with a 10-fold
excess of cold methionine up to 10 h. As shown in Fig.
3c, the 132-, 97-, and 74-kDa proteins were detected after
labeling for 2 h and remained detectable after chase for
10 h. The 39- and 35-kDa proteins appeared after chase
for 2 h and were increased gradually with time (Fig. 3c).
Further analysis of the expression and processing
of products encoded by the 39-terminal region
of ORF 1b
As shown in Fig. 3a, the 132-kDa protein encoded by
pIBV1b4 contains two putative Q-S cleavage sites
(Q2012(1b)-S2013(1b) and Q2350(1b)-S2351(1b)). Cleavage at
these two positions would result in the formation of three
mature products with calculated molecular masses of 58,
38, and 34 kDa, respectively. The apparent molecular
masses of 39 and 35 kDa of the two proteins detected
from coexpression of pIBV1b4 and pIBV3C suggest that
they may represent the two C-terminal cleavage prod-
ucts. To investigate this possibility, plasmid pIBV1b5 was
constructed and expressed in Vero cells. This plasmid
covers the IBV sequence from nucleotides 18,930 to
20,874 and has the potential to encode a product of 59
kDa (Fig. 4a). Transfection of pIBV1b5 alone led to the
synthesis of a polypeptide of approximately 59 kDa, con-
sistent with the calculated full-length product of 59 kDa
encoded by this construct (Fig. 4b, lane 1). As expected,
two additional products with apparent molecular masses
of 24 and 35 kDa were produced from coexpression of
pIBV1b5 and pIBV3C (Fig. 4b, lane 2). The 35-kDa protein
comigrates on SDS–PAGE with the 35-kDa protein pro-
duced from coexpression of pIBV1b4 and pIBV3C (Fig.
4b, lanes 2 and 4), indicating that they are the same
cleavage product from the C-terminal region of the 1b
polyprotein. However, the detection of the 35-kDa protein
from coexpression of pIBV1b5 and pIBV3C was dispro-
portionately more efficient than that from coexpression of
pIBV1b4 and pIBV3C (Fig. 4b, lanes 2 and 4). The reason
for this discrepancy is currently uncertain.
Mutational analysis of the putative Q2350(1b)-S2351(1b)
and Q2012(1b)-S2013(1b) cleavage sites
The results presented above suggest that cleavage of
the 1b polyprotein by the 3C-like proteinase may occur at
the Q2350(1b)-S2351(1b) dipeptide bond, resulting in the re-
lease of a mature product of 35 kDa. To support further if
cleavage did occur at this position, substitution of the
Q2350(1b) residue with an E was introduced by site-
FIG. 2—Continued
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directed mutagenesis, giving a mutant construct
pIBV1b4Q2350(1b)-E. Expression of this plasmid in Vero
cells resulted in the synthesis, once again, of the full-
length 132-kDa polyprotein (Fig. 5, lane 1). Coexpression
of pIBV1b4Q2350(1b)-E with pIBV3C led to the detection of
an additional protein of approximately 74 kDa (Fig. 5,
lanes 2 and 5). This product comigrates on SDS–PAGE
with the 74-kDa protein detected from cotransfection of
pIBV1b4 and pIBV3C (Fig. 5, lanes 5 and 6). No other
cleavage products were detected (Fig. 5, lanes 1 and 5),
FIG. 3. (a) Diagram showing the IBV sequences present in plasmids pIBV1b4 and pIBV3C. The UAG termination codon for ORF 1b (encoded by
nucleotides 20,415 to 20,417) and the IBV sequence used to raise antiserum V17 are indicated. Also shown are the two predicated Q-S
(Q2012(1b)-S2013(1b) and Q2350(1b)-S2351(1b)) dipeptide bonds and the predicted cleavage products that could be detected by immunoprecipitation with
antiserum V17. (b) Analysis of transiently expressed products from transfection of pIBV1b4 and cotransfection of pIBV1b4 and pIBV3C. Cells were
labeled with [35S]methionine, lysates were prepared, and polypeptides were immunoprecipitated with antiserum V17. The radiolabeled polypeptides
were separated on an SDS–12.5% polyacrylamide gel and detected by fluorography. Numbers indicate molecular mass in kilodaltons. (c) Pulse–chase
analysis of the expression, processing, and accumulation of products from cotransfection of pIBV1b4 and pIBV3C. Cells were labeled with
[35S]methionine for 4 h at 13 h posttransfection, chased with a 10-fold excess of cold methionine, and harvested after chase for 0, 2, 4, 6, 8, and 10 h.
Cell lysates were then prepared and were either analyzed directly or subjected to immunoprecipitation with antiserum V17. The radiolabeled
polypeptides were separated on an SDS–12.5% polyacrylamide gel and detected by fluorography. HMW, high molecular weight markers (numbers
indicate kilodaltons).
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suggesting that mutation of the Q2350(1b) residue to an E
did block the cleavage occurring at this position. This
result indicates that the Q2350(1b)-S2351(1b) dipeptide bond
may be the cleavage site responsible for releasing the
N-terminus of the 35-kDa protein and the C-terminus of
the 39-kDa protein from the 1b polyprotein. The 74-kDa
protein detected from coexpression of pIBV1b4 and
pIBV3C is therefore representing an intermediate cleav-
age product encoded by ORF 1b from nucleotides 18,495
to 20,414.
Substitution of the Q2012(1b) residue of the predicted
Q2012(1b)-S2013(1b) cleavage site with an E was subse-
quently made by site-directed mutagenesis, giving a mu-
tant construct pIBV1b4Q2012(1b)-E. Coexpression of this
plasmid with pIBV3C led to the synthesis of three protein
species, the 132-kDa protein and two products comi-
grated, respectively, with the 97- and 35-kDa proteins
detected from coexpression of pIBV1b4 and pIBV3C (Fig.
5, lanes 4 and 6). No 39- and 74-kDa proteins were
detected (Fig. 5, lane 4), suggesting that mutation of the
Q2012(1b) residue to an E abolished cleavage occurring at
the Q2012(1b)-S2013(1b) bond. This result indicates that the
Q2012(1b)-S2013(1b) dipeptide bond is recognized and
cleaved by the 3C-like proteinase to release the N-ter-
minus of the 39-kDa protein and the C-terminus of a
putative 58-kDa protein. The 97-kDa protein detected
from coexpression of pIBV1b4 and pIBV3C is therefore
an intermediate cleavage product containing the 39- and
58-kDa proteins.
Identification of novel gene 1 products encoded by
the ORF 1b region in IBV-infected Vero cells
Data presented above indicate that the 35- and 39-kDa
proteins may represent mature viral products processed
from the C-terminal region of the 1b polyprotein. To
confirm this possibility, confluent monolayers of Vero
cells were infected with IBV at a multiplicity of infection
(m.o.i.) of approximately 2 PFU per cell and were labeled
for 4 h with [35S]methionine at 6 h postinfection. Cell
lysates were prepared and subjected to immunoprecipi-
tation with antisera V58 and V17. As can be seen, anti-
serum V58 precipitated specifically, once again, the 100-
kDa protein from IBV-infected cell lysates (Fig. 6, lane 3)
(also see Liu et al., 1994, 1997). Immunoprecipitation of
the same cell lysate with antiserum V17 led to the de-
tection of two polypeptides with apparent molecular
masses of 39 and 35 kDa, respectively; no other inter-
mediate cleavage products were detected (Fig. 6, lane 4).
Once again, very weak immunoprecipitation of the 35-
kDa protein was observed (Fig. 6, lane 4). These two
products comigrated on SDS–PAGE with the 39- and
35-kDa proteins detected from coexpression of pIBV1b4
and pIBV3C (data not shown).
DISCUSSION
Coronavirus IBV encodes a proteinase belonging to
the picornavirus 3C proteinase group. The available ev-
idence suggests that this proteinase may play a major
FIG. 4. (a) Diagram showing the IBV sequence present in plasmids pIBV1b4 and pIBV1b5. The UAG termination codon for ORF 1b (encoded by
nucleotides 20,415 to 20,417) and the IBV sequence used to raise antiserum V17 are indicated. Also shown are the two predicated Q-S
(Q2012(1b)-S2013(1b) and Q2350(1b)-S2351(1b)) dipeptide bonds and the predicted cleavage products that could be detected by immunoprecipitation with
antiserum V17. (b) Analysis of transiently expressed products from cotransfection of pIBV1b5 and pIBV3C. Cells were labeled with [35S]methionine,
lysates were prepared, and polypeptides were immunoprecipitated with antiserum V17. The radiolabeled polypeptides were separated on an
SDS–12.5% polyacrylamide gel and detected by fluorography. Numbers indicate molecular mass in kilodaltons.
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role in processing of the 1a and 1a/1b polyproteins into
mature viral products associated with viral RNA replica-
tion. In a previous report, we showed that a 100-kDa
mature viral protein was released from the 1a/1b
polyprotein by the 3C-like proteinase at two Q-S dipep-
tide bonds (Q3928-S3929 and Q891(1b)-S892(1b)) (Liu et al.,
1994; Liu and Brown, 1995) (see Fig. 1). In this report, we
demonstrate that the 3C-like proteinase may also medi-
ate cleavage at other three predicted Q-S(G) dipeptide
bonds (Q1491(1b)-G1492(1b), Q2012(1b)-S2013(1b) and Q2350(1b)-
S2351(1b)) located in the 1b region of the 1a/1b polyprotein
(see Fig. 1). In addition to the 100-kDa protein, four
mature viral products with calculated molecular masses
of approximately 68, 58, 38, and 34 kDa would be re-
leased from the 1a/1b polyprotein by cleavage at these
positions (see Fig. 1). Indeed, two polypeptides of 39 and
35 kDa, corresponding to the two C-terminal cleavage
products of the 1a/1b polyprotein, were identified in
IBV-infected Vero cells.
Attempts have been made to detect the rest two cleav-
age products (the putative 68- and 58-kDa proteins) in
virus-infected cells. Mutagenesis studies presented in
this report strongly suggest that the two predicted cleav-
age sites (Q1491(1b)-G1492(1b) and Q2012(1b)-S2013(1b)) flank-
ing the putative 58-kDa protein are genuine cleavage
sites of the 3C-like proteinase. The expression and pro-
cessing patterns shown also lend support to the genuine
presence of the 58-kDa protein. In order to detect this
product, a region-specific antiserum was raised in rab-
bits and was shown to be able to precipitate specifically
the in vitro synthesized target products (data not shown).
However, further application of this antiserum in identi-
fication of the putative 58-kDa protein from IBV-infected
cells was hampered by the fact that it can cross-react
with a cellular protein migrating on SDS–PAGE at ap-
proximately the same position as the 58-kDa protein (Liu
et al., unpublished observations). Two antisera against
the putative 68-kDa metal-binding and helicase protein
have been raised in rabbits. Both antisera can efficiently
recognize the in vitro synthesized target proteins. How-
ever, it was consistently found that no specific processed
product can be detected in cells either infected with IBV
or transfected with plasmids covering the region. As the
equivalent protein has recently been identified in cells
infected with human coronavirus (Heusipp et al., 1997a),
it is likely that the 68-kDa protein is a genuine viral
product. We are currently uncertain if the failure to detect
this product is due to its rapid degradation in intact cells.
Systematic analysis of the expression and accumulation
of this putative protein is underway to address this pos-
sibility.
As both the putative 68- and 58-kDa proteins are
currently undetectable in intact cells and expression of
FIG. 5. Mutational analysis of the predicted Q2350(1b)S2351(1b) and
Q2012(1b)S2013(1b) cleavage sites. The mutants were transiently ex-
pressed in Vero cells using the vaccinia virus-T7 expression system.
The transfected cells were labeled with [35S]methionine, lysates were
prepared, and polypeptides were immunoprecipitated with antiserum
V17. The radiolabeled polypeptides were separated on an SDS–12.5%
polyacrylamide gel and detected by fluorography. Numbers indicate
molecular mass in kilodaltons.
FIG. 6. Detection of a 39- and a 35-kDa protein in IBV-infected Vero
cells. Confluent monolayers of Vero cells were infected with IBV at a
m.o.i. of 2 PFU per cell. The IBV-infected (‘I’) and mock-infected (‘M’)
cells were labeled with [35S]methionine, lysates were prepared, and
polypeptides were immunoprecipitated with antisera V58 (lanes 1 and
3) and V17 (lanes 2 and 4). The radiolabeled polypeptides were sepa-
rated on an SDS–12.5% polyacrylamide gel and detected by fluorogra-
phy. Numbers indicate molecular mass in kilodaltons.
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the region encoding the putative 68-kDa protein is elu-
sive, the previously predicted Q1491(1b)-G1492(1b) cleavage
site was studied by using region-specific antiserum V58.
For the same reason, plasmid pIBV14D1Q891(1b)-E, a con-
struct containing two deletions and a mutation of the
Q891(1b) residue to an E, was expressed to study the
expression and processing pattern of the regions flank-
ing this site. The results generated as well as the mu-
tagenesis studies reported here suggest that the
Q1491(1b)-G1492(1b) dipeptide bond is a real scissile bond of
the 3C-like proteinase. The rest two predicted cleavage
sites (Q2012(1b)-S2013(1b) and Q2350(1b)-S2351(1b)) were stud-
ied based on the trans-cleavage activity of the 3C-like
proteinase. Once again, data generated from expres-
sion, deletion and mutagenesis studies indicate that
they are genuine cleavage sites of the 3C-like protein-
ase. However, coexpression, pulse-chase and time
course experiments presented in this study showed
that cleavage at these two positions is much less
efficient than other cleavage sites identified (Liu and
Brown, 1995; Liu et al., 1997). As can be seen in Fig.
3c, the 97-kDa and 74-kDa intermediate cleavage
products remained detectable even after chase for
10 h, suggesting that these two Q-S dipeptide bonds
may be poor cleavage sites of the 3C-like proteinase.
However, no intermediate cleavage products could be
detected in virus-infected cells (Fig. 6). This may re-
flect some regulatory mechanisms controlling the bal-
ance between the production and accumulation of the
proteinase and its substrate in virus-infected cells. In
IBV-infected cells, the 3C-like proteinase is produced
approximately five times as much as the 1a/1b
polyprotein, as the 1a/1b polyprotein is expressed by
ribosome frameshifting and the frameshifting effi-
ciency is 25–30% (Brierley et al., 1987, 1989). Approx-
imately equal amounts of the proteinase and sub-
strate, however, would be expected to be produced in
a single cell by coexpression of two plasmids. It is
therefore understandable that complete cleavage of
the 1a/1b polyprotein can be achieved in virus-in-
fected cells by an excess amount of the proteinase.
Nevertheless, it would be of interest to define the
sequence determinants that dictate the cleavage effi-
ciency of a particular substrate.
Currently, no functional domain has been found in the
regions encoding the 39- and 35-kDa proteins. A coun-
terpart of the IBV 39-kDa protein, the human coronavirus
41-kDa protein, has recently been shown to exhibit a
punctate, perinuclear distribution in virus-infected cells
(Heusipp et al., 1997b), indicating that it may be located
in the membranous compartment. It would be of interest
to see if the 39-kDa protein shows a similar cellular
distribution to the 41-kDa protein. This possibility as well
as the significance of such a distribution in viral RNA
replication is currently under investigation.
MATERIALS AND METHODS
Virus and cells
The egg-adapted Beaudette strain of IBV (ATCC VR-22)
was obtained from the American Type Culture Collection
(ATCC) and was adapted to Vero cells as described by
Alonso-Caplen et al. (1984). Briefly, the virus was pas-
saged three times in 11-day-old chicken embryos and
then adapted to Vero cells (ATCC CCL-81) by a series of
passages at 24- to 48-h intervals. The cytopathic effects,
including syncytium formation and rounding up of cells,
were initially observed after three passages in Vero cells.
Virus stocks were prepared after the 36th passage by
infecting monolayers of Vero cells at a m.o.i. of approx-
imately 0.1 PFU/cell. The virus was harvested at 24 h
postinfection and the titer of the virus preparation was
determined by plaque assay on Vero cells.
Vero cells were grown at 37°C in 5% CO2 and main-
tained in Glasgow’s modified minimal essential medium
(GMEM) supplemented with 10% newborn calf serum.
Labeling of IBV-infected cells with [35S]methionine
Confluent monolayers of Vero cells were infected with
IBV at a m.o.i. of approximately 2 PFU/cell. Prior to being
labeled, the cells were incubated in methionine-free me-
dium for 30 min. After 4 h of labeling with 25 mCi [35S]me-
thionine, the cells were scraped off the dishes in phos-
phate-buffered saline, recovered by centrifugation, and
stored at 280°C.
Transient expression of IBV sequences in Vero cells
using a vaccinia-T7 expression system
Open reading frames placed under control of the T7
promoter were expressed transiently in eukaryotic cells
as described previously (Liu et al., 1994). Briefly, semi-
confluent monolayers of Vero cells were infected with 10
PFU/cell of a recombinant vaccinia virus (vTF7-3) which
expresses the bacteriophage T7 RNA polymerase and
then transfected with the appropriate plasmid DNA using
DOTAP transfection reagent according to the instructions
of the manufacturer (Boehringer Mannheim). After incu-
bation of the cells at 37°C for 4 h, 25 mCi/ml [35S]methi-
onine was added directly to the medium. The radiola-
beled cells were harvested at 18 h posttransfection.
Polymerase chain reaction (PCR)
Appropriate primers and template DNAs were used in
amplification reactions with Pfu DNA polymerase (Strat-
agene) under standard buffer conditions with 2 mM
MgCl2. PCR conditions were 30 cycles of 95°C for 45 s,
X°C for 45 s, and 72°C for X min. The annealing temper-
ature (X°C) and the extension time (X min) were adjusted
according to the melting temperature of the primers used
and the length of the PCR fragments synthesized.
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Site-directed mutagenesis
Site-directed mutagenesis was carried out, as previ-
ously described (Liu and Brown, 1995), using single-
stranded DNA templates prepared from plasmid pIBV1b4
and appropriate oligonucleotide primers.
Substitution mutation of the Q1491(1b)-G1492(1b) dipep-
tide bond was introduced by two rounds of PCR using
two pairs of primers, as previously described (Liu et al.,
1997).
Radioimmunoprecipitation
Plasmid DNA-transfected Vero cells were lysed with
RIPA buffer (50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1%
sodium deoxycholate, 0.1% SDS, 1% NP-40) and pre-
cleared by centrifugation at 12,000 rpm for 5 min at 4°C
in a microfuge. Immunoprecipitation was carried out as
described previously (Liu et al., 1994).
SDS–polyacrylamide gel electrophoresis
SDS–polyacrylamide gel electrophoresis (SDS–PAGE)
of virus polypeptides was carried out using 12.5% poly-
acrylamide gels (Laemmli, 1970). Labeled polypeptides
were detected by autoradiography or fluorography of
dried gels.
Construction of plasmids
Plasmid pIBV1b4 was made by cloning an NcoI- and
BamHI-digested PCR fragment into NcoI- and BamHI-
digested pKTO (Liu et al., 1994). The PCR fragment cov-
ers the IBV sequence from nucleotides 16,932 to 20,490
and contains an artificial AUG initiation codon in an
optimal context (ACCAUGG) located immediately up-
stream of the viral sequence. The sequence of the up-
stream primer used to generate this PCR fragment was
59-ACAAGTCCCATGGGTACAGGTT-39, and the down-
stream primer was 59-GCACCCCCGGGATCCTGCCAAC-
39. Plasmid pIBV1b5 was constructed by cloning an
SnaBI- and DraI-digested fragment containing the IBV
sequence from nucleotides 18,930 to 20,874 into EcoRV-
and SmaI-digested pKTO and selected by nucleotide
sequencing.
Two mutants with alterations at the putative Q2350(1b)-
S2351(1b) and Q2012(1b)-S2013(1b) cleavage sites were made
by site-directed mutagenesis using single-stranded DNA
templates prepared from plasmid pIBV1b4. Plasmid
pIBV1b4Q2350(1b)-E was made by site-directed mutagen-
esis using oligonucleotide primer 59-TCCACAGCTT-
GAATCAGCATG-39, and pIBV1b4Q2012(1b)-E was made by
using oligonucleotide primer 59-TTCAGCTCTCGAGTC-
TATCGAC-39.
Plasmid pIBV14D1Q891(1b)-E, which contains the
Q891(1b) to an E mutation (Liu and Brown, 1995), was used
to construct plasmid pIBV21 as follows. An 842-bp PCR
fragment, which covers the IBV sequence from nucleo-
tides 16,788 to 17,630 and contains a Q1491(1b) to M1491(1b)
mutation, was generated by PCR. This PCR fragment
was then digested with PstI, gel-purified, and ligated into
PstI- and SmaI-digested pIBV14D1Q891(1b)-E, giving plas-
mid pIBV21. The sequence of the oligonucleotide primer
used to introduce the mutation was 59-ACAAGTCCCAT-
GGGTACAGGTT-39, and the sequence of the comple-
mentary primer was 59-AACAAACCTGTACCCATGGGAC-
39. This construct was selected by restriction digestion
with NcoI and confirmed by automated nucleotide se-
quencing.
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